Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral propranolol vs intralesional betamethasone for small, localized infantile hemangiomas at high cosmetic risk
ChiCTR2200064613Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Capillary Haemangioma comparing Oral propranolol treatment group with Intralesional betamethasone injection treatment group (2 arms). Primary endpoints: Hemangioma volume and Adverse events and incidence. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
propranololbetamethasone
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on ChiCTR2200064613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064613.